Loading...

Expanding Facilities And Secular Trends Will Fuel Peptide Therapeutics Demand

Published
25 Jun 25
n/a
n/a
AnalystHighTarget's Fair Value
n/a
Loading
1Y
-33.4%
7D
-5.4%

Author's Valuation

CHF 10049.1% undervalued intrinsic discount

AnalystHighTarget Fair Value